Saxenda (Liraglutide)

Saxenda® (liraglutide) injection 3 mg is a prescription medicine used for weight loss in adults with
excess weight or obesity and in children aged 12-17 years with obesity. It is designed to be used
alongside a reduced-calorie diet and increased physical activity.

Table of Contents:

  1. What is Saxenda?
  2. How does Saxenda work?
  3. Side Effects and Warnings
  4. Usage Instructions
  5. Special Considerations
  6. Drug Interactions and Contraindications
  7. Storage
  8. Disclaimer

What is Saxenda?

  • Active Ingredient: Liraglutide.
  • Drug Class: Glucagon-like peptide-1 (GLP-1) agonists.
  • Indications: Weight loss in obese adults (BMI ≥30) or overweight adults (BMI ≥27) with
    weight-related medical problems, and in children aged 12-17 years with obesity.
  • Administration: Subcutaneous injection once a day from a multi-dose injection pen.

How Does Saxenda Work?

  • Saxenda aids weight loss by decreasing appetite, slowing gastric emptying, and thereby reducing
    calorie intake. It is similar to a hormone that occurs naturally in the body and helps control blood
    sugar, insulin levels, and digestion.

Side Effects and Warnings

  • Common Side Effects:Include nausea, diarrhea, constipation, vomiting, injection site
    reactions, low blood sugar (hypoglycemia), headache, tiredness, dizziness, and stomach pain.
  • Serious Side Effects: Can include pancreatitis, gallbladder problems, low blood sugar,
    increased heart rate, kidney problems, serious allergic reactions, and depression or thoughts of
    suicide. Saxenda may cause thyroid tumors, including cancer, and should not be used by those with a
    personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia
    syndrome type 2 (MEN 2).

Usage Instructions

  • Saxenda should be injected under the skin once per day. It can be injected at any time of the day,
    with or without a meal, and should not be used together with Victoza (another brand containing
    liraglutide) or other GLP-1 receptor agonist medicines.

Special Considerations

  • Contraindications: Do not use Saxenda if you are allergic to liraglutide, have MTC or MEN 2,
    diabetic ketoacidosis, or are pregnant.
  • Pregnancy and Breastfeeding: Not recommended for use in pregnancy and breastfeeding. It is
    not known if Rybelsus will harm an unborn baby, and breastfeeding is not recommended during
    treatment with Rybelsus.

Drug Interactions and Contraindications

  • Inform your healthcare provider about all the medicines you take, including prescription,
    over-the-counter medicines, vitamins, and herbal supplements, as Saxenda may affect the way some
    medicines work and vice versa


  • Store unopened Saxenda pens in the refrigerator. After the first injection, it may be refrigerated
    or stored at controlled room temperature for 30 days. Keep the pen out of direct heat and sunlight.


Saxenda® is a prescription medication and should only be used under the guidance of a healthcare
professional. The information provided here is for educational purposes only and is not a substitute for
professional medical advice, diagnosis, or treatment. Always consult your healthcare provider for any
questions regarding your health or medications. The brand name ‘Saxenda®’ is used for informational
purposes and does not imply endorsement of any specific medication, service, or treatment. The
information is compiled from various sources and may change. It does not cover all possible uses,
actions, precautions, side effects, or interactions of the drug. For more detailed information, refer to
the official prescribing information and consult with healthcare providers.